J&J and Merck heading for showdown over drug rights

September 8, 2010
Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

inVentiv Health acquires French advertising group

September 8, 2010
Medical Communications France, advertising, inVentiv Health

InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …

Pharma sector optimism growing

September 8, 2010
Sales and Marketing Eversheds, economic climate

Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …

Greece to cut 4,000 drug prices by a fifth

September 8, 2010
Sales and Marketing Greece, economic climate, price cuts, pricing & Reimbursement

The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …

Andreotti

BMS to acquire ZymoGenetics

September 8, 2010
Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …

GSK patient recruitment head joins Exco InTouch

September 8, 2010
Research and Development Exco InTouch, appointment, research and development

Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …

Dr Meena Jain

Working Life: Dr Meena Jain

September 8, 2010
Business Services, Research and Development Napp, Working Life, careers, recruitment

How did you find your way into your most current role? I’ve been at Napp for four years now having …

PCT managers have ‘no automatic right’ to GP commissioning

September 8, 2010
GP, NHS, commissioning, government

Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …

Pfizer drops brain cancer vaccine

September 7, 2010
Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …

Roche signs Alzheimer’s deal with reMYND

September 7, 2010
Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …

Merck averts day in court over Dutch plant closure

September 7, 2010
Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …

FDA cites another Sun Pharma unit for GMP violations

September 7, 2010
Manufacturing and Production Sun Pharma, manufacturing compliance

Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …

Pharma manufacturing news in brief

September 7, 2010
Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys

A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …

Stephen Stamp joins board at Eusa Pharma

September 7, 2010
Sales and Marketing Eusa Pharma, appointment, sales and marketing

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …

Russian API manufacturer eyes IPO and acquisitions

September 7, 2010
Manufacturing and Production API, Pharmsynthez, Russia

Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …

New form of Levitra wins EU approval

September 7, 2010
Sales and Marketing Bayer, Levitra, erectile dysfunction

Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …

Pressure mounts on GSK over Avandia

September 6, 2010
Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …

Parallel trading restricting medicine access, says ABPI

September 6, 2010
Sales and Marketing parallel trade, pharmacists, supply chain

The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …

Next generation Malaria drug shows promise

September 6, 2010
Research and Development malaria

A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …

Olivier Bohuon takes post at Pierre Fabre

September 6, 2010
Sales and Marketing Pierre Fabre, appointment, sales and marketing

French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …

The Gateway to Local Adoption Series

Latest content